Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non‐myeloablative allogeneic stem cell transplantation
Year: 2003
Type: article
Study design: Observational Study
Abstract: Little is known about the impact of cytomegalovirus (CMV) infections that occur after human leucocyte antigen (HLA)-matched unrelated donor (MUD) non-myleoablative haematopoietic stem cell transplantation (HCT). We analysed the incidence, onset and outcomes of CMV infections in 59 recipients of MUD and in 109 recipients of HLA-matched related donor (MRD) allogeneic HCT following non-myeloablative conditioning containing 2 Gy total body irradiation and fludarabine. In CMV seropositive recipients, antigenaemia occurred in 68% (MUD) and in 49% (MRD, P = 0.08); there were no differences in the maximum levels of CMV antigenaemia and the time to cessation with antiviral therapy. CMV viraemia by culture was more common in MUD compared with MRD HCT recipients in univariate analysis (26% vs. 6%, P = 0.01), however, this difference was not detectable after controlling for other factors. The rates of CMV disease in the first 100 d were similar in MUD (9%) and MRD (5%) HCT recipients. CMV disease tended to occur earlier in the MUD compared with the MRD recipients (median day 41 vs. day 80). Beyond day 100, rates of CMV disease remained similar in both cohorts (cumulative incidence: MUD 21% and MRD 14%). The 30-d and 1-year survivals after CMV disease diagnosis were not significantly different in both groups. Thus, there appeared to be a trend toward increased CMV reactivation in MUD compared with MRD non-myeloablative allogeneic HCT recipients; however, these differences did not reach statistical significance in this cohort and preemptive therapy was similarly effective in preventing CMV diseases.
Source: British Journal of Haematology
Institutions: Fred Hutch Cancer Center, University of Washington
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1140547312, G232612905, G2878308015, G30144808, G3247483315, IMMUNOLOGIC STUDIES IN STEM CELL GRAFTS FOR MALIGNANCIES, G451230947, Stem Cell Transplantation: Basic/Clinical Research, G4857603760, G6390593869, CD34+ CELLS TO ACHIEVE HEMATOPOIETIC CHIMERISM, G8443266990, G9000031333, G9000036597, G9000089784, G9000135638, G9000345474, Cancer Center Support Grant, Adult Leukemia Research Center, Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
OpenAlex ID: W2041419725